HomeCompareUTME vs MRK

UTME vs MRK: Dividend Comparison 2026

UTME yields 432.25% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 UTME wins by $20293.77M in total portfolio value
10 years
UTME
UTME
● Live price
432.25%
Share price
$0.46
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20293.83M
Annual income
$13,946,685,318.87
Full UTME calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — UTME vs MRK

📍 UTME pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodUTMEMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, UTME + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
UTME pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

UTME
Annual income on $10K today (after 15% tax)
$36,740.87/yr
After 10yr DRIP, annual income (after tax)
$11,854,682,521.04/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, UTME beats the other by $11,854,674,192.63/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of UTME + MRK for your $10,000?

UTME: 50%MRK: 50%
100% MRK50/50100% UTME
Portfolio after 10yr
$10146.94M
Annual income
$6,973,347,558.50/yr
Blended yield
68.72%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

UTME
No analyst data
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

UTME buys
0
MRK buys
0
No recent congressional trades found for UTME or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricUTMEMRK
Forward yield432.25%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$20293.83M$56.8K
Annual income after 10y$13,946,685,318.87$9,798.13
Total dividends collected$19721.78M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: UTME vs MRK ($10,000, DRIP)

YearUTME PortfolioUTME Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$53,925$43,224.55$11,206$366.19+$42.7KUTME
2$275,537$217,837.81$12,650$502.35+$262.9KUTME
3$1,335,087$1,040,262.62$14,407$694.19+$1.32MUTME
4$6,139,280$4,710,736.64$16,585$967.82+$6.12MUTME
5$26,813,799$20,244,769.16$19,342$1,363.89+$26.79MUTME
6$111,326,892$82,636,126.92$22,913$1,947.19+$111.30MUTME
7$439,767,315$320,647,540.73$27,662$2,823.89+$439.74MUTME
8$1,654,320,129$1,183,769,102.09$34,159$4,173.35+$1654.29MUTME
9$5,931,909,341$4,161,786,803.07$43,337$6,308.80+$5931.87MUTME
10$20,293,828,314$13,946,685,318.87$56,776$9,798.13+$20293.77MUTME

UTME vs MRK: Complete Analysis 2026

UTMEStock

United Time Technology Co., Ltd., through its subsidiaries, designs, develops, manufactures, and sells mobile phones, accessories, and related consumer electronics. It also offers consumer electronics, such as power banks, Bluetooth speakers, batteries, chargers, and cell phone parts, molds, and shells; and distributes face masks. In addition, the company provides electronics manufacturing services, including original equipment manufacturer and original design manufacturer services. It sells its products under the UTime and Do brand names in South America, South Asia, Southeast Asia, and Africa. The company was incorporated in 2008 and is headquartered in Shenzhen, China. United Time Technology Co., Ltd. was a former subsidiary of Nollec Wireless Company, Ltd.

Full UTME Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this UTME vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

UTME vs SCHDUTME vs JEPIUTME vs OUTME vs KOUTME vs MAINUTME vs JNJUTME vs ABBVUTME vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.